In the phase one clinical trial, eight patients who received the vaccine at the lowest and middle doses developed neutralising antibodies to the virus.
Moderna’s technology, which involves genetic material from the virus called mRNA, is relatively new and has yet to produce any approved vaccine.
A Covid-19 vaccine that has been developed by an American biotechnology company has been found to be safe and able to stimulate an immune response in the humans against the virus, its manufacturer, Moderna, announced on Monday.
This is the first coronavirus vaccine to be tested in people. The findings are based on results from the first eight people who each received two doses of the experimental vaccine.
